Circulating Neurofilament Light Predicts Cognitive Decline in Patients With Post-stroke Subjective Cognitive Impairment
- PMID: 34079450
- PMCID: PMC8165181
- DOI: 10.3389/fnagi.2021.665981
Circulating Neurofilament Light Predicts Cognitive Decline in Patients With Post-stroke Subjective Cognitive Impairment
Abstract
Background: Subjective cognitive impairment (SCI) is common after acute ischemic stroke and adversely affects the quality of life. SCI is associated with an increased risk of developing mild cognitive impairment and dementia. Identifying biomarkers which could predict long-term cognitive outcomes of post-stroke SCI is of importance for early intervention. This study aims to investigate the association between circulating neurofilament light (NfL) and long-term cognitive function in patients with post-stroke SCI.
Methods: This longitudinal study recruited 304 patients with post-stroke SCI, and serum NfL levels were determined at baseline. These patients were followed up for 12 months for the observation of cognitive change. Cognitive performances were assessed by a Chinese version of the Telephone Interview of Cognitive Status-40 (TICS-40) scale.
Results: The patients were divided into a progression group (as determined by decreased TICS-40 scores) and a stable group (as determined by increased or unchanged TICS-40 scores). The progression group had significantly higher serum NfL levels than the stable group at baseline. Serum NfL levels were predictive for longitudinal cognitive decline during follow-up.
Conclusion: These findings imply that circulating NfL could predict the long-term cognitive change of patients with post-stroke SCI.
Keywords: acute ischemic stroke; biomarker; neurofilament light; prognosis; subjective cognitive impairment (SCI).
Copyright © 2021 Wang, Huang, Guo, Wang, Yang, Yu, Zheng and Wang.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures


Similar articles
-
Serum Neurofilament Light Predicts 6-Month Mental Health Outcomes in a Cohort of Patients With Acute Ischemic Stroke.Front Psychiatry. 2022 Feb 7;12:764656. doi: 10.3389/fpsyt.2021.764656. eCollection 2021. Front Psychiatry. 2022. PMID: 35197872 Free PMC article.
-
Combination of Serum Neurofilament Light Chain Levels and MRI Markers to Predict Cognitive Function in Ischemic Stroke.Neurorehabil Neural Repair. 2021 Mar;35(3):247-255. doi: 10.1177/1545968321989354. Epub 2021 Feb 1. Neurorehabil Neural Repair. 2021. PMID: 33522401
-
Neurofilament light: a possible prognostic biomarker for treatment of vascular contributions to cognitive impairment and dementia.J Neuroinflammation. 2021 Oct 15;18(1):236. doi: 10.1186/s12974-021-02281-1. J Neuroinflammation. 2021. PMID: 34654436 Free PMC article.
-
Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease.JAMA Neurol. 2019 Jul 1;76(7):791-799. doi: 10.1001/jamaneurol.2019.0765. JAMA Neurol. 2019. PMID: 31009028 Free PMC article.
-
Neurofilament Light Chain (NfL) in Blood-A Biomarker Predicting Unfavourable Outcome in the Acute Phase and Improvement in the Late Phase after Stroke.Cells. 2021 Jun 18;10(6):1537. doi: 10.3390/cells10061537. Cells. 2021. PMID: 34207058 Free PMC article. Review.
Cited by
-
Serum Neurofilament Light Predicts 6-Month Mental Health Outcomes in a Cohort of Patients With Acute Ischemic Stroke.Front Psychiatry. 2022 Feb 7;12:764656. doi: 10.3389/fpsyt.2021.764656. eCollection 2021. Front Psychiatry. 2022. PMID: 35197872 Free PMC article.
-
Blood biomarkers for vascular cognitive impairment based on neuronal function: a systematic review and meta-analysis.Front Neurol. 2025 Feb 7;16:1496711. doi: 10.3389/fneur.2025.1496711. eCollection 2025. Front Neurol. 2025. PMID: 39990267 Free PMC article. Review.
-
Cognitive recovery in patients with post-stroke subjective cognitive complaints.Front Neurol. 2022 Sep 27;13:977641. doi: 10.3389/fneur.2022.977641. eCollection 2022. Front Neurol. 2022. PMID: 36237629 Free PMC article.
-
Recent contributions to the field of subjective cognitive decline in aging: A literature review.Alzheimers Dement (Amst). 2023 Oct 18;15(4):e12475. doi: 10.1002/dad2.12475. eCollection 2023 Oct-Dec. Alzheimers Dement (Amst). 2023. PMID: 37869044 Free PMC article. Review.
-
Serum neurofilament heavy chain predicts post-stroke cognitive impairment.Sci Rep. 2025 Apr 19;15(1):13556. doi: 10.1038/s41598-025-96952-1. Sci Rep. 2025. PMID: 40253401 Free PMC article.
References
-
- Harrison J. K., Stott D. J., Mcshane R., Noel-Storr A. H., Swann-Price R. S., Quinn T. J. (2016). Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) for the early diagnosis of dementia across a variety of healthcare settings. Cochrane Database Syst. Rev. 11:CD011333. - PMC - PubMed
-
- Hu X., Teunissen C. E., Spottke A., Heneka M. T., Duzel E., Peters O., et al. (2019). Smaller medial temporal lobe volumes in individuals with subjective cognitive decline and biomarker evidence of Alzheimer’s disease-Data from three memory clinic studies. Alzheimers Dement. 15 185–193. 10.1016/j.jalz.2018.09.002 - DOI - PubMed
LinkOut - more resources
Full Text Sources